SB 866 — Pennsylvania
An Act amending the act of April 14, 1972 (P.L.233, No.64), known as The Controlled Substance, Drug, Device and Cosmetic Act, further providing for schedules of controlled substances and for secure storage of xylazine; and adding provisions relating to medetomidine.
Pennsylvania legislative agenda & upcoming votes Pennsylvania session calendar
Summary
- SB 866 is a bill in the Pennsylvania Senate, 2025-2026 session, introduced July 24, 2025.
- Sponsored by Michele Brooks, with 3 cosponsors.
- Current status: passed one chamber.
- Most recent action (June 10, 2026): Referred to Judiciary.
- 3 recorded votes; the most recent, on June 9, 2026, passed 47-2.
-
State Senator, District 50
Republican
Contact your legislator about this bill
Bill text & documents
Sponsors
Primary: Michele Brooks
Cosponsors (3): Doug Mastriano, Christine Tartaglione, Lisa Boscola
History
- Introduced, completed
- Passed Senate, completed
- Passed House, in progress
- Sent to Governor, not reached yet
- Signed into law, not reached yet
- Senate Referred to Agriculture & Rural Affairs
-
Senate
Reported as committed
Committee vote (Agriculture & Rural Affairs): Reported as Committed: 11 yes 0 no Passed, 100% yes
- Senate First consideration
- Senate Second consideration
- Senate Re-referred to Appropriations
-
Senate
Re-reported as committed
Committee vote (Appropriations): Re-Reported as Committed: 22 yes 0 no Passed, 100% yes
-
Senate
Third consideration and final passage
Milestone
FINAL PASSAGE: 47 yes 2 no, 1 other Passed, 96% yes
- House Referred to Judiciary Latest